Long-Term (1 Year) Safety and Efficacy of Methylphenidate Modified-Release Long-Acting Formulation (MPH-LA) in Adults with Attention-Deficit Hyperactivity Disorder: A 26-Week, Flexible-Dose, Open-Label Extension to a 40-Week, Double-Blind, Randomised, Placebo-Controlled Core Study
CNS DRUGS. Bd. 28. H. 10. 2014 S. 951-962
Erscheinungsjahr: 2014
Publikationstyp: Zeitschriftenaufsatz
| Geprüft | Bibliothek |
Autoren
Ginsberg, Y. (Autor)
Arngrim, T. (Autor)
Philipsen, A. (Autor)
Gandhi, P. (Autor)
Chen, C. -W. (Autor)
Kumar, V. (Autor)
Huss, M. (Autor)
Klassifikation
DDC Sachgruppe:
Medizin
